Gen Digital Inc. (GEN) reported third-quarter fiscal 2025 results, wherein revenues matched the Zacks Consensus Estimate and earnings beat the same.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Gen Digital reported non-GAAP earnings of 56 cents per share, which improved 15% year over year and on a constant currency basis. In the third quarter, the bottom line came at the high end of management's guidance of 54-56 cents, exceeding the Zacks Consensus Estimate by 1.8%. This resulted f ...

Core Insights - Gen Digital reported revenue of $986 million for the quarter ended December 2024, reflecting a year-over-year increase of 3.5% [1] - The company's EPS was $0.56, up from $0.49 in the same quarter last year, exceeding the consensus estimate of $0.55 [1] - The revenue surpassed the Zacks Consensus Estimate of $985.73 million by 0.03% [1] Financial Performance Metrics - Direct average revenue per user (ARPU) was $7.27, slightly above the average estimate of $7.26 [4] - The direct customer count reached 40.1 million, exceeding the average estimate of 39.85 million [4] - Cyber Safety Revenue from partner revenues was reported at $105 million, close to the average estimate of $105.14 million, marking a year-over-year increase of 6.1% [4] - Cyber Safety Revenue from direct customer revenues was $869 million, slightly above the average estimate of $868.47 million, with a year-over-year growth of 3.8% [4] Stock Performance - Gen Digital's shares returned +0.9% over the past month, compared to a +1.2% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3]

Core Viewpoint - Gen Digital (GEN) reported quarterly earnings of $0.56 per share, exceeding the Zacks Consensus Estimate of $0.55 per share, and showing an increase from $0.49 per share a year ago, indicating a positive earnings surprise of 1.82% [1] Financial Performance - The company achieved revenues of $986 million for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 0.03%, and up from $953 million in the same quarter last year [2] - Over the last four quarters, Gen Digital has exceeded consensus EPS estimates two times and topped consensus revenue estimates four times [2] Stock Performance and Outlook - Gen Digital shares have increased by approximately 0.9% since the beginning of the year, while the S&P 500 has gained 2.7% [3] - The company's future stock performance will largely depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] Earnings Estimates - The current consensus EPS estimate for the upcoming quarter is $0.57 on revenues of $1 billion, and for the current fiscal year, it is $2.19 on revenues of $3.93 billion [7] - The estimate revisions trend for Gen Digital is mixed, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Technology Services industry, to which Gen Digital belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Q3 FY25 Earnings January 30, 2025 Copyright © 2025 Gen Digital Inc. All rights reserved. Forward-Looking Statements This presentation contains statements which may be considered forward-looking within the meaning of the U.S. federal securities laws. In some cases, you can identify these forward-looking statements by the use of terms such as "expect," "will," "continue," or similar expressions, and variations or negatives of these words, but the absence of these words does not mean that a statement is not fo ...

Core Insights - Gen Digital Inc. reported strong Q3 results for fiscal year 2025, with revenue of $986 million, a 4% increase year-over-year, and operating income of $374 million, up 13% [5][11][12] - The company has strengthened its full-year guidance, expecting revenue between $3,915 million and $3,930 million, and EPS in the range of $2.20 to $2.22 [6][8] - Gen Digital emphasizes the growing demand for comprehensive consumer Cyber Safety solutions, reflecting its commitment to protecting customer data and assets [2][7] Financial Performance - Q3 FY25 revenue was $986 million, with a 4% increase in both USD and constant currency [5][22] - Operating income reached $374 million, resulting in an operating margin of 38%, which is a 3-point increase [5][11] - Diluted EPS for Q3 was $0.26, an 18% increase compared to the previous year [5][11] Guidance and Dividends - The company expects Q4 FY25 revenue to be between $990 million and $1,005 million, with EPS projected between $0.57 and $0.59 [6][8] - Gen's Board of Directors approved a quarterly cash dividend of $0.125 per common share, to be paid on March 12, 2025 [3] Customer Metrics - Direct customer revenues for Q3 were $869 million, up from $834 million, with a direct customer count of 40.1 million [22][23] - The retention rate improved to 78%, up from 77% year-over-year [23] Strategic Focus - Gen Digital is focused on strategic investments and disciplined execution to sustain momentum and drive future success in the Cyber Safety market [2][7] - The company aims to enhance customer trust by providing practical solutions to address evolving threats and protect personal information [1][2]

Core Viewpoint - Gen Digital Inc. is expected to report its third-quarter fiscal 2025 results on January 30, with anticipated non-GAAP revenues between $980 million and $990 million, reflecting a year-over-year growth of 3.4% [1][2]. Financial Performance Expectations - The consensus estimate for Gen Digital's revenues is $985.7 million, while non-GAAP earnings are projected to be between 54 and 56 cents per share, with a consensus mark of 55 cents per share, indicating a year-over-year increase of 12.2% [2]. - In the previous four quarters, Gen Digital's earnings have shown mixed results, beating the consensus once, missing once, and matching twice, with an average negative surprise of 0.02% [3]. Market and Demand Factors - The company's performance is likely to benefit from increased demand for cybersecurity products due to a significant rise in global hacking incidents, which has led to a growing client base [4][5]. - The launch of Norton Small Business Premium, a comprehensive cybersecurity solution, is expected to enhance sales in the upcoming quarter, with estimated revenues for the Consumer Security segment at $621.1 million, a 3.2% year-over-year increase [6]. - The Identity and Information Protection division is projected to see revenues of $351.9 million, indicating a growth of 5.4% from the previous year [6]. - Strong demand for identity theft protection solutions and strategic partnerships are anticipated to contribute positively to top-line growth [7]. Challenges and Economic Context - Despite the positive outlook, Gen Digital's performance may be affected by a decline in IT spending due to high interest rates and inflation, which are impacting consumer spending and leading enterprises to defer IT investments [8]. - Ongoing macroeconomic and geopolitical challenges are also expected to influence the company's fiscal third-quarter results [8]. Earnings Prediction Model - According to the Zacks model, Gen Digital currently has an Earnings ESP of 0.00% and a Zacks Rank of 3 (Hold), indicating that the odds of an earnings beat are not favorable at this time [9].

Company Overview - Genmab is an international biotechnology company headquartered in Copenhagen, Denmark, with a presence across North America, Europe, and Asia Pacific [3] - The company focuses on developing innovative and differentiated antibody therapeutics to improve the lives of patients with cancer and other serious diseases [2] - Genmab has a proprietary pipeline that includes bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function-enhanced antibodies [2] - By 2030, the company aims to transform patient lives with its KYSO (knock-your-socks-off) antibody medicines [2] Product Performance - Worldwide net trade sales of DARZALEX (daratumumab) in 2024 totaled USD 11,670 million, including USD 6,588 million in the U S and USD 5,082 million in the rest of the world [1] - The sales include both the intravenous product and the subcutaneous (SC) product, sold under the tradename DARZALEX FASPRO in the U S [1] - Genmab receives royalties on the worldwide net sales of DARZALEX under an exclusive license agreement with Johnson & Johnson (J&J) [1][5] Business Model - Genmab operates under a royalty-based model for DARZALEX, leveraging J&J's global development, manufacturing, and commercialization capabilities [1] - The company owns several trademarks, including Genmab, HuMax, DuoBody, HexaBody, DuoHexaBody, HexElect, and KYSO, while DARZALEX and DARZALEX FASPRO are trademarks of Johnson & Johnson [5]

Core Insights - Avast has launched its identity protection solution, Avast Secure Identity, in 15 new countries outside the US to combat rising identity theft and scam risks [1][4] Group 1: Product Expansion - Avast Secure Identity is now available in countries including the UK, France, Germany, Australia, New Zealand, Brazil, Mexico, Spain, and Italy [4] - The expansion aims to provide more individuals with tools to protect their identities amid increasing cyber threats [3] Group 2: Cybersecurity Landscape - There has been a significant rise in large-scale data breaches, which cybercriminals exploit to commit identity theft [2] - The Q3/2024 Gen Threat Report noted a 614% increase in "Scam-Yourself Attacks," where individuals are manipulated into compromising their own devices [2] Group 3: Key Features of Avast Secure Identity - Continuous monitoring of personal information across private forums and the dark web, with notifications for detected data [3][6] - Restoration support from Identity Restoration Specialists to assist victims of identity theft [6] - Additional features include dark web monitoring, social media monitoring, financial monitoring, and identity theft insurance available in specific regions [6]

Core Viewpoint - Gen Digital Inc. is set to release its fiscal 2025 third quarter financial results on January 30, 2025, after market close, followed by a conference call and webcast [1][2]. Company Overview - Gen Digital Inc. (NASDAQ: GEN) is a global company focused on empowering Digital Freedom through its cybersecurity brands, including Norton, Avast, LifeLock, Avira, AVG, ReputationDefender, and CCleaner [2]. - The company aims to provide safety for the first digital generations and currently serves nearly 500 million users across more than 150 countries [2].

Company Update Presentation - Genmab's CEO, Jan van de Winkel, will present a company update at the 43rd Annual J P Morgan Healthcare Conference on January 14, 2025, at 3:00 PM PST / 6:00 PM EST [1] - The presentation will be available via live and archived webcast on Genmab's website [1] Company Overview - Genmab is an international biotechnology company focused on developing innovative antibody therapeutics to improve the lives of patients with cancer and other serious diseases [2] - The company has over 25 years of experience in inventing next-generation antibody technology platforms, leveraging translational, quantitative, and data sciences [2] - Genmab's proprietary pipeline includes bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators, and effector function-enhanced antibodies [2] - By 2030, the company aims to transform patient lives with its "knock-your-socks-off" (KYSO) antibody medicines [2] - Genmab was established in 1999 and is headquartered in Copenhagen, Denmark, with a global presence across North America, Europe, and Asia Pacific [2] Trademarks and Legal Information - Genmab and its subsidiaries own several trademarks, including Genmab, the Y-shaped Genmab logo, HuMax, DuoBody, HexaBody, DuoHexaBody, HexElect, and KYSO [4]